Referências

1. Abrous, D.N., Adriani, W., Montaron, M.F., Nicotine self administration impairs hippocampal plasticity (2002) J Neurosci, 22, pp. 3656-3662
2. Almeid, O., Tama, S., Congestive heart failure and cognitive functioning amongst older adult (2001) Arq Neuropsiquiat, 5, pp. 324-332
3. Almeid, O., Garrid, G., Lautenschlage, N., Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient alzheimer diseas (2008) Am J Geriatr Psychiatry, 16, pp. 92-99
4. Alves, T.C., Rays, J., Fraguas, R., Localized cerebral blood flow reductions in patients with heart failure: A study using 99mtc-hmpao spect (2005) J Neuroimaging, 15, pp. 150-156
5. Anstey, K.J., Von Sanden, C., Salim, A., Smoking as a risk factor for dementia and cognitive decline: A meta-analysis of prospective studies (2007) Am J Epidemiol, 166, pp. 367-378
6. Antonelli Incalzi, R., Trojano, L., Acanfora, D., Verbal memory impairment in congestive heart failure (2003) J Clin Exp Neuropsychol, 25, pp. 14-23
7. Aston, J.A., Cunningham, V.J., Asselin, M.C., Positron emission tomography partial volume correction: Estimation and algorithms (2002) J Cereb Blood Flow Metab, 22, pp. 1019-1034
8. Bake, L.D., Cros, D.J., Minoshim, S., Insulin resistance and alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabete (2011) Arch Neurol, 6, pp. 51-55
9. Bange, K.J., Resto, K., Li, T.T., Differential age effects on cerebral blood flow and bold response to encoding: Associations with cognition and stroke risk (2009) Neurobiol Aging, 30, pp. 1276-1287
10. Beason-Held, L.L., Thambisetty, M., Deib, G., Baseline cardiovascular risk predicts subsequent changes in resting brain function (2012) Stroke, 43, pp. 1542-1547
11. Bell, R.D., Deane, R., Chow, N., Srf and myocardin regulate lrp-mediated amyloid-beta clearance in brain vascular cells (2009) Nat Cell Biol, 11, pp. 143-153
12. Bellomo, A., Mancinella, M., Troisi, G., Relationship between atrial fibrillation and other cardiovascular risk factors in alzheimer’s disease. New prevention opportunities (2009) Recenti Prog Med, 100, pp. 124-126
13. Bennett, S.J., Sauve, M.J., Cognitive deficits in patients with heart failure: A review of the literature (2003) J Cardiovasc Nurs, 18, pp. 219-242
14. Berlau, D.J., Corrada, M.M., Head, E., Apoe epsilon2 is associated with intact cognition but increased alzheimer pathology in the oldest old (2009) Neurology, 72, pp. 829-834
15. Bottino, C.M., Azevedo, D., Jr., Tatsch, M., Estimate of dementia prevalence in a community sample from sao paulo, brazil (2008) Dement Geriatr Cogn Disord, 26, pp. 291-299
16. Braak, E., Griffing, K., Arai, K., Neuropathology of alzheimer’s disease: What is new since a. Alzheimer? (1999) Eur Arch Psychiatry Clin Neurosci, 249, pp. 14-22
17. Braskie, M.N., Klunder, A.D., Hayashi, K.M., Plaque and tangle imaging and cognition in normal aging and alzheimer’s disease (2010) Neurobiol Aging, 31, pp. 1669-1678
18. Breteler, M.M., Claus, J.J., Grobbee, D.E., Cardiovascular disease and distribution of cognitive function in elderly people: The rotterdam study (1994) BMJ, 308, pp. 1604-1608
19. Buchman, A.S., Boyle, P.A., Yu, L., Total daily physical activity and the risk of ad and cognitive decline in older adults activity (2012) Neurology, 78, pp. 1323-1329
20. Chen, Z., Li, L., Sun, J., Mapping the brain in type ii diabetes: Voxel-based morphometry using dartel (2011) Eur J Radiol, 81, pp. 1870-1876
21. Chetelat, G., Desgranges, B., De La Sayette, V., Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment (2003) Brain, 126, pp. 1955-1967
22. Chetelat, G., Villemagne, V.L., Bourgeat, P., Relationship between atrophy and beta- amyloid deposition in alzheimer disease (2010) Ann Neurol, 67, pp. 317-324
23. Curiati, P.K., Tamashiro-Duran, J.H., Duran, F.L.S., Age-related metabolic profiles in cognitively healthy elders: Results from a voxel-based [18f] fluorodeoxyglucose-positron-emission tomography study with partial volume effects correction (2011) AJNR am J Neuroradiol, 32, pp. 560-565
24. Dai, W., Lopez, O.L., Carmichael, O.T., Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension (2008) Stroke, 39, pp. 349-354
25. Das, S.K., Bos, P., Biswa, A., An epidemiologic study of mild cognitive impairment in kolkata, india (2007) Neurolog, 6, pp. 2019-2202
26. De Felice, F.G., Wu, D., Lambert, M.P., Alzheimer’s disease-type neuronal tau hyperphosphorylation induced by ap oligomers (2008) Neurobiol Aging, 29, pp. 1334-1347
27. De La Torre, J.C., Critical threshold cerebral hypoperfusion causes alzheimer’s disease? (1999) Acta Neuropathol, 98, pp. 1-8
28. De La Torre, J.C., Three postulates to help identify the cause of Alzheimer’s disease (2011) J Alzheimers Dis, 24, pp. 657-668
29. De La Torre, J.C., Pappas, B.A., Prevot, V., (2003) Neurol Res, 25, pp. 635-641
30. de Toledo Ferraz Alves, T.C., Scazufca, M., Squarzoni, P., Subtle gray matter changes in temporo-parietal cortex associated with cardiovascular risk factors (2011) J Alzheimers Dis, 27, pp. 575-589
31. Debette, S., Beiser, A., De Carli, C., Association of mri markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: The framingham offspring study (2010) Stroke, 41, pp. 600-606
32. Drzezga, A., Grimmer, T., Riemenschneider, M., Prediction of individual clinical outcome in mci by means of genetic assessment and (18)f-fdg pet (2005) J Nucl Med, 46, pp. 1625-1632
33. Elias, M.F., Elias, P.K., Sullivan, L.M., Lower cognitive function in the presence of obesity and hypertension: The framingham heart study (2003) Int J Obes Relat Metab Disord, 27, pp. 260-268
34. Erkinjuntt, T., Gauthie, S., The concept of vascular cognitive impairment (2009) Front Neurol Neurosci, 2, pp. 79-88
35. Weidemann, E.G., Biogenesis and metabolism of alzheimer’s disease a beta amyloid peptides (2002) Peptides, 23, pp. 1285-1297
36. Fitzpatrick, A.L., Kuller, L.H., Lopez, O.L., Midlife and late-life obesity and the risk of dementia: Cardiovascular health study (2009) Arch Neurol, 66, pp. 336-342
37. Forlenz, O.V., Spink, J.M., Dayananda, R., Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via gsk-3beta inhibition and in neurons (2000) J Neural Trans, 107, pp. 1201-2121
38. Forsberg, A., Engler, H., Almkvist, O., Pet imaging of amyloid deposition in patients with mild cognitive impairment (2008) Neurobiol Aging, 29, pp. 1456-1465
39. Fristo, K.J., Holme, K.J., Polin, J.B., Detecting activations in pet and fmri: Levels of inference and power (1996) Neuroimage, 4, pp. 223-235
40. Gabryelewicz, T., Styczynska, M., Luczywek, E., The rate of conversion of mild cognitive impairment to dementia: Predictive role of depression (2007) Int J Geriatr Psychiatry, 22, pp. 563-567
41. Gimbrone, M.A., The gordon wilson lecture. Understanding vascular endothelium: A pilgrim’s progress. Endothelial dysfunction, biomechanical forces and the pathobiology of atherosclerosis (2010) Trans am Clin Climatol Assoc, 121, pp. 115-127
42. Glynn, L.M., Christenfeld, N., Gerin, W., The role of rumination in recovery from reactivity: Cardiovascular consequences of emotional states (2002) Psychosom Med, 64, pp. 714-726
43. Gouw, A.A., Seewann, A., Van Der Flier, W.M., Heterogeneity of small vessel disease: A systematic review of mri and histopathology correlations (2011) J Neurol Neurosurg Psychiatry, 82, pp. 126-135
44. Grammas, P., A damaged microcirculation contributes to neuronal cell death in alzheimer’s disease (2000) Neurobiol Aging, 21, pp. 199-205
45. Grammas, P., Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of alzheimer’s disease (2011) J Neuroinflammation, 8, 26p
46. Grammas, P., Martinez, J., Miller, B., Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases (2011) Expert Rev Mol Med, 13, pp. e19
47. Gruhn, N., Larsen, F.S., Boesgaard, S., Cerebral blood flow in patients with chronic heart failure before and after heart transplantation (2001) Stroke, 32 (11), pp. 2530-2533
48. Hardy, J., Selkoe, D.J., The amyloid hypothesis of alzheimer’s disease: Progress and problems on the road to therapeutics (2002) Science, 297, pp. 353-356
49. Havlik, R.J., Foley, D.J., Sayer, B., Variability in midlife systolic blood pressure is related to late-life brain white matter lesions: The honolulu-asia aging study (2002) Stroke, 33, pp. 26-30
50. Head, D., Bugg, J.M., Goate, A.M., Exercise engagement as a moderator of the effects of apoe genotype on amyloid deposition (2012) Arch Neurol, 69, pp. 636-643
51. Hernandez, F., De Barreda, E.G., Fuster-Matanzo, A., The role of gsk3 in alzheimer disease (2009) Brain Res Bull, 80, pp. 248-250
52. Iri, F., Fitzpatric, A.L., Lopez, O.L., Enhanced risk for alzheimer disease in persons with type 2 diabetes and apoe epsilon4: The cardiovascular health study cognition study (2008) Arch Neurol, 6, pp. 89-93
53. Iwatsubo, T., Odaka, A., Suzuki, N., Visualization of a beta 42(43) and a beta 40 in senile plaques with end-specific a beta monoclonals: Evidence that an initially deposited species is a beta 42(43) (1994) Neuron, 13, pp. 45-53
54. Jack, C.R., Jr., Lowe, V.J., Weigand, S.D., Serial pib and mri in normal, mild cognitive impairment and alzheimer’s disease: Implications for sequence of pathological events in alzheimer’s disease (2009) Brain, 132, pp. 1355-1365
55. Jagust, W., Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia (2006) Alzheimers Dement, 2, pp. 36-42
56. Jagus, W.J., Band, D., Chen, K., The alzheimer’s disease neuroimaging initiative positron emission tomography cor (2010) Alzheimers Demen, 6, pp. 221-229
57. Jeerakathil, T., Wolf, P.A., Beiser, A., Stroke risk profile predicts white matter hyperintensity volume: The framingham study (2004) Stroke, 35, pp. 1857-1861
58. Kawach, T., Ishii, K., Sakamot, S., Comparison of the diagnostic performance of fdg- pet and vbm-mri in very mild alzheimer’s disease (2006) Eur J Nucl Med Mol Imaging, 33, pp. 801-880
59. Kearney-Schwartz, A., Rossignol, P., Bracard, S., Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints (2009) Stroke, 40, pp. 1229-1236
60. Kivipelto, M., Helkal, E.L., Hannine, T., Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study (2001) Neurolog, 56, pp. 1683-2168
61. Kivipelto, M., Rovio, S., Ngandu, T., Apolipoprotein E. Epsilon4 magnifies lifestyle risks for dementia: A population-based study (2008) J Cell Mol Med, 12, pp. 2762-2771
62. Kochunov, P., Ramage, A.E., Lancaste, J.L., Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging (2009) Neuroimag, 45, pp. 17-22
63. Kohler, S., Thomas, A.J., Lloyd, A., White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression (2010) Br J Psychiatry, 196, pp. 143-149
64. Koivunen, J., Scheinin, N., Virta, J.R., Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study (2011) Neurology, 76 (12), pp. 1085-1090
65. Korf, E.S., Van Straaten, E.C., De Leeuw, F.E., Diabetes mellitus, hypertension and medial temporal lobe atrophy: The ladis study (2007) Diabet Med, 24, pp. 166-171
66. Kuczynski, B., Jagust, W., Chui, H.C., An inverse association of cardiovascular risk and frontal lobe glucose metabolism (2009) Neurology, 72, pp. 738-743
67. Langbaum, J.B., Chen, K., Caselli, R.J., Hypometabolism in alzheimer-affected brain regions in cognitively healthy latino individuals carrying the apolipoprotein (2010) E Epsilon4 Allele. Arch Neurol, 67, pp. 462-468
68. Langbaum, J.B., Chen, K., Launer, L.J., Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons (2012) Neurobiol Aging, 33 (827), pp. e11-e19
69. Launer, L.J., Masaki, K., Petrovitch, H., The association between midlife blood pressure levels and late-life cognitive function. The honolulu-asia aging study (1995) JAMA, 274, pp. 1846-1851
70. Lee, J., Kim, M.S., The role of gsk3 in glucose homeostasis and the development of insulin resistance (2007) Diabetes Res Clin Pract, 77, pp. 49-57
71. Le, P., Ayto, S., Bus, A.I., Gsk-3 in neurodegenerative diseases. Int j alzheimers di (2011) Int J Alzheimers Dis.
72. Li, J., Wan, Y.J., Zhang, M., Vascular risk factors promote conversion from mild cognitive impairment to alzheimer disease (2011) Neurology, 76, pp. 1485-1491
73. Liang, K.Y., Mintun, M.A., Fagan, A.M., Exercise and alzheimer’s disease biomarkers in cognitively normal older adults (2010) Ann Neurol, 68, pp. 311-318
74. Liu, Y., Paajanen, T., Westman, E., Apoe epsilon2 allele is associated with larger regional cortical thicknesses and volumes (2010) Dement Geriatr Cogn Disord, 30, pp. 229-237
75. Longstreth, W.T., Jr., Arnold, A.M., Beauchamp, N.J., Jr., Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: The cardiovascular health study (2005) Stroke, 36, pp. 56-61
76. Lopez, O.L., Jagust, W.J., Dulberg, C., Risk factors for mild cognitive impairment in the cardiovascular health study cognition study: Part 2 (2003) Arch Neurol, 60, pp. 1394-1399
77. Luchsinge, J.A., Reit, C., Honi, L.S., Aggregation of vascular risk factors and risk of incident alzheimer disease (2005) Neurology, 65, pp. 545-5551
78. Luchsinger, J.A., Reitz, C., Patel, B., Relation of diabetes to mild cognitive impairment (2007) Arch Neurol, 64, pp. 570-575
79. Markus, H.S., Hunt, B., Palmer, K., Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: Longitudinal results of the austrian stroke prevention study (2005) Stroke, 36, pp. 1410-1414
80. Meigs, J.B., Singer, D.E., Sullivan, L.M., Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (Niddm): The niddm patient outcome research team (1997) Am J Med, 102, pp. 38-47
81. Meltze, C.C., Cantwel, M.N., Gree, P.J., Does cerebral blood flow decline in healthy aging? A pet study with partial-volume correctio (2000) J Nucl Med, 41, pp. 1842-1848
82. Meno, U., Kelle, R.E., Subcortical ischemic cerebrovascular dementia (2009) Int Rev Neurobio, 84, pp. 21-33
83. Minoshima, S., Giordani, B., Berent, S., Metabolic reduction in the posterior cingulate cortex in very early alzheimer’s disease (1997) Ann Neurol, 42, pp. 85-94
84. Moscon, L., Brain glucose metabolism in the early and specific diagnosis of alzheimer’s disease. Fdg-pet studies in mci and ad (2005) Eur J Nucl Med Mol Imagin, 32, pp. 486-510
85. Mosconi, L., De Santi, S., Brys, M., Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 Carriers with Subjective Memory Complaints (2008) Biol Psychiatry, 63, pp. 609-618
86. Mosconi, L., Tsui, W.H., Herholz, K., Multicenter standardized 18f-fdg pet diagnosis of mild cognitive impairment, alzheimer’s disease, and other dementias (2008) J Nucl Med, 49, pp. 390-398
87. Nurk, E., Refsum, H., Tell, G.S., Plasma total homocysteine and memory in the elderly: The hordaland homocysteine study (2005) Ann Neurol, 58, pp. 847-857
88. Obisesa, T.O., Obisesan, O.A., High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: The third national health and nutrition examination survey (2008) J am Geriatr Soc, 56, pp. 501-509
89. Oliveira-Da-Silva, A., Vieira, F.B., Cristina-Rodrigues, F., Increased apoptosis and reduced neuronal and glial densities in the hippocampus due to nicotine and ethanol exposure in adolescent mice (2009) Int J Dev Neurosci, 27, pp. 539-548
90. Paulso, O.B., Jarde, J.O., Vorstru, S., Effect of captopril on the cerebral circulation in chronic heart failur (1986) Eur J Clin Inves, 16, pp. 124-132
91. Peter, R., Becket, N., Hypertension, dementia, and antihypertensive treatment: Implications for the very elderly (2009) Curr Hypertens Rep, 11, pp. 277-282
92. Petersen, R.C., Mild cognitive impairment as a diagnostic entity (2004) J Intern Med, 256, pp. 183-194
93. Petrie, E.C., Cross, D.J., Galasko, D., Preclinical evidence of alzheimer changes: Convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings (2009) Arch Neurol, 66, pp. 632-637
94. Plassma, B., Lang, K., Fishe, G., Prevalence of dementia in the united states: The aging, demographics, and memory study (2007) Neuroepidemiology, 29, pp. 125-132
95. Purandare, N., Preventing dementia: Role of vascular risk factors and cerebral emboli (2009) Br Med Bull, 91, pp. 49-59
96. Purnell, C., Gao, S., Callahan, C.M., Cardiovascular risk factors and incident alzheimer disease: A systematic review of the literature (2009) Alzheimer Dis Assoc Disord, 23, pp. 1-10
97. Rabinovici, G.D., Jagus, W.J., Amyloid imaging in aging and dementia: Testing the amyloid hypothesis in vivo (2009) Behav Neurol, 21, pp. 117-128
98. Rajagopalan, B., Raine, A.E., Cooper, R., Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment (1984) Am J Med, 76, pp. 86-90
99. Raza, G., Vreugdenhi, A., Wilcoc, G., The metabolic syndrome and alzheimer disease (2007) Arch Neurol, 64, pp. 93-96
100. Refsum, H., Ueland, P.M., Nygard, O., Homocysteine and cardiovascular disease (1998) Annu Rev Med, 49, pp. 31-62
101. Reiman, E.M., Chen, K., Alexander, G.E., Functional brain abnormalities in young adults at genetic risk for late-onset alzheimer’s dementia (2004) Proc Natl Acad Sci U S A, 101, pp. 284-289
102. Reiman, E.M., Chen, K., Langbaum, J.B., Functional brain abnormalities in young adults at genetic risk for late-onset alzheimer’s dementia (2010) Neuroimage, 49, pp. 169-176
103. Reitz, C., Tang, M.X., Manly, J., Hypertension and the risk of mild cognitive impairment (2007) Arch Neurol, 64, pp. 1734-1740
104. Rocchi, A., Orsucci, D., Tognoni, G., The role of vascular factors in late-onset sporadic alzheimer’s disease. Genetic and molecular aspects. Genetic and molecular aspects (2009) Curr Alzheimer Res, 6, pp. 224-237
105. Rosendorff, C., Beeri, M.S., Silverman, J.M., Cardiovascular risk factors for Alzheimer’s disease (2007) Am J Geriatr Cardiol, 16, pp. 143-149
106. Rosengart, T.K., Sweet, J., Finnin, E.B., Neurocognitive functioning in patients undergoing coronary artery bypass graft surgery or percutaneous coronary intervention: Evidence of impairment before intervention compared with normal controls (2005) Ann Thorac Surg, 80, pp. 1327-1334
107. Rostru, E., Gou, A.A., Vrenke, H., The spatial distribution of age-related white matter changes as a function of vascular risk factors-results from the ladis study (2012) Neuroimag, 60, pp. 1597-2160
108. Salmina, A.B., Inzhutova, A.I., Malinovskaya, N.A., Endothelial dysfunction and repair in alzheimer-type neurodegeneration: Neuronal and glial control (2010) J Alzheimers Dis, 22, pp. 17-36
109. Scarmeas, N., Luchsinger, J.A., Schupf, N., Physical activity, diet, and risk of Alzheimer disease (2009) JAMA, 302, pp. 627-637. , a
110. Scarmeas, N., Stern, Y., Mayeux, R., Mediterranean diet and mild cognitive impairment (2009) Arch Neurol, 66, pp. 216-225. , b
111. Scazufca, M., Menezes, P.R., Vallada, H.P., High prevalence of dementia among older adults from poor socioeconomic backgrounds in sao paulo, brazil (2008) Int Psychogeriatr, 20, pp. 394-405
112. Seshadri, S., Methodology for measuring cerebrovascular disease burden (2006) Int Rev Psychiatry, 18, pp. 409-422
113. Sims-Robinson, C., Kim, B., Rosko, A., How does diabetes accelerate alzheimer disease pathology? (2010) Nat Rev Neurol, 6, pp. 551-559
114. Skoo, I., Lernfel, B., Landahl s et al (1996) 15-year longitudinal study of blood pressure and dementi Lancet, 34, pp. 1141-2114
115. Small, B.J., Rosnick, C.B., Fratiglioni, L., Apolipoprotein E and cognitive performance: A meta-analysis (2004) Psychol Aging, 19, pp. 592-600
116. Soderlund, H., Nyberg, L., Adolfsson, R., High prevalence of white matter hyperintensities in normal aging: Relation to blood pressure and cognition (2003) Cortex, 39, pp. 1093-1105
117. Solfrizzi, V., D’ Introno, A., Colacicco, A.M., Circulating biomarkers of cognitive decline and dementia (2006) Clin Chim Acta, 364, pp. 91-112
118. Solomon, A., Kareholt, I., Ngandu, T., Serum cholesterol changes after midlife and late- life cognition: Twenty-one-year follow-up study (2007) Neurology, 68, pp. 751-756
119. Stuerenburg, H.J., Ganzer, S., Arlt, S., The influence of smoking on plasma folate and lipoproteins in alzheimer disease, mild cognitive impairment and depression (2005) Neuro Endocrinol Lett, 26, pp. 261-263
120. Taguchi, A., Vascular factors in diabetes and alzheimer’s disease (2009) J Alzheimers Dis, 16, pp. 859-864
121. Tamashiro-Duran, J.H., Squarzoni, P., Duran, F., Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations (2013) Age (Dordr), 35 (3), pp. 777-792
122. Teipel, S.J., Meindl, T., Wagner, M., White matter microstructure in relation to education in aging and alzheimer’s disease (2009) J Alzheimers Dis, 17, pp. 571-583
123. Viswanathan, A., Rocca, W.A., Tzourio, C., Vascular risk factors and dementia: How to move forward? (2009) Neurology, 72, pp. 368-374
124. Volkow, N.D., Wang, G.J., Telang, F., Inverse association between bmi and prefrontal metabolic activity in healthy adults (2009) Obesity (Silver Spring), 17, pp. 60-65
125. Wilso, P.W., D’ Agostin, R.B., Levy, D., Prediction of coronary heart disease using risk factor categories (1998) Circulatio, 97, pp. 1837-2184
126. Xu, W., Qiu, C., Gatz, M., Mid- and late-life diabetes in relation to the risk of dementia: A population-based twin study (2009) Diabetes, 58, pp. 71-77
127. Yanas, D., Matsunar, I., Yajim, K., Brain fdg pet study of normal aging in japanese: Effect of atrophy correctio (2005) Eur J Nucl Med Mol Imaging, 32, pp. 794-880
128. Zlokovic, B.V., Neurovascular mechanisms of alzheimer’s neurodegeneration (2005) Trends Neurosci, 28, pp. 202-208
129. Zlokovic, B.V., Neurodegeneration and the neurovascular unit (2010) Nat Med, 16, pp. 1370-1371